PCM
BMY icon

Polymer Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Polymer Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$365K Sell
6,023
-4,918
-45% -$287K 0.04% 528
2025
Q4 		$590K Buy
10,941
+3,525
+48% +$170K 0.06% 427
2025
Q3 		$334K Buy
+7,416
New +$346K 0.04% 584

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Polymer Capital Management's BMY Position: Q1 2026 in Review

Polymer Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 45% in Q1 2026, selling an estimated $287K and leaving 6,023 shares worth $365K. The position accounts for 0.04% of the portfolio, ranked #528.

Polymer Capital Management first reported a position in BMY in Q3 2025 and has held it in 3 quarters since. The position peaked at $590K in Q4 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Polymer Capital Management held 6,023 shares of Bristol-Myers Squibb worth $365K as of Q1 2026.
  • Polymer Capital Management sold 4,918 Bristol-Myers Squibb shares in Q1 2026, an estimated $287K.
  • Bristol-Myers Squibb made up 0.04% of Polymer Capital Management's portfolio in Q1 2026, its #528 holding.
  • Polymer Capital Management first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 3 quarters since.
  • Polymer Capital Management's Bristol-Myers Squibb position peaked at $590K in Q4 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Polymer Capital Management's 13F filing for Q1 2026, filed 14 May 2026.